Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency
Objective: To report the first prenatal dopaminergic replacement therapy in autosomal recessive (AR) guanosine triphosphate cyclohydrolase 1 (GTPCH) deficiency without hyperphenylalaninemia.<h3>Design</h3>Case reports, literature review, and video presentation. Setting: University of Lü...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2, 2012
|
| In: |
Archives of neurology
Year: 2012, Volume: 69, Issue: 8, Pages: 1071-1075 |
| ISSN: | 1538-3687 |
| DOI: | 10.1001/archneurol.2012.104 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1001/archneurol.2012.104 Verlag, kostenfrei, Volltext: https://jamanetwork.com/journals/jamaneurology/fullarticle/1151838 |
| Author Notes: | Norbert Brüggemann, Juliane Spiegler, Yorck Hellenbroich, Thomas Opladen, Susanne A. Schneider, Ulrich Stephani, Rainer Boor, Gabriele Gillessen-Kaesbach, Jürgen Sperner, Christine Klein |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580952399 | ||
| 003 | DE-627 | ||
| 005 | 20220815010834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180913s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/archneurol.2012.104 |2 doi | |
| 035 | |a (DE-627)1580952399 | ||
| 035 | |a (DE-576)510952399 | ||
| 035 | |a (DE-599)BSZ510952399 | ||
| 035 | |a (OCoLC)1341018459 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Brüggemann, Norbert |d 1976- |e VerfasserIn |0 (DE-588)131447432 |0 (DE-627)509449115 |0 (DE-576)298483939 |4 aut | |
| 245 | 1 | 0 | |a Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency |c Norbert Brüggemann, Juliane Spiegler, Yorck Hellenbroich, Thomas Opladen, Susanne A. Schneider, Ulrich Stephani, Rainer Boor, Gabriele Gillessen-Kaesbach, Jürgen Sperner, Christine Klein |
| 264 | 1 | |c April 2, 2012 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.09.2018 | ||
| 520 | |a Objective: To report the first prenatal dopaminergic replacement therapy in autosomal recessive (AR) guanosine triphosphate cyclohydrolase 1 (GTPCH) deficiency without hyperphenylalaninemia.<h3>Design</h3>Case reports, literature review, and video presentation. Setting: University of Lübeck, Lübeck, Germany. Patients: Two boys from a consanguineous family. Main Outcome Measures: Physical and mental development as a function of replacement initiation. Results: The older sibling presented with typical features of AR GTPCH deficiency due to a homozygous mutation in the GCH1 gene with proven pathogenicity. Levodopa treatment was initiated at age 10 months and resulted in a distinct motor improvement. However, mental development was delayed. In the younger sibling, prenatal replacement therapy was initiated after a prenatal diagnosis of AR GTPCH deficiency was made. At age 17 months, both motor and mental development were normal for his age. Conclusions: This report highlights the importance of an early diagnosis, including prenatal diagnosis, of complex dopa-responsive extrapyramidal syndromes. Prenatally initiated dopaminergic replacement therapy is beneficial and thus justified in AR GTPCH deficiency, allowing prevention of significant impairment of mental abilities. | ||
| 700 | 1 | |a Opladen, Thomas |d 1974- |e VerfasserIn |0 (DE-588)124489656 |0 (DE-627)642820481 |0 (DE-576)335321291 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of neurology |d [Chicago, Ill.] : Assoc., 1960 |g 69(2012), 8, Seite 1071-1075 |h Online-Ressource |w (DE-627)26876090X |w (DE-600)1473074-1 |w (DE-576)088704114 |x 1538-3687 |7 nnas |a Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency |
| 773 | 1 | 8 | |g volume:69 |g year:2012 |g number:8 |g pages:1071-1075 |g extent:5 |a Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/archneurol.2012.104 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://jamanetwork.com/journals/jamaneurology/fullarticle/1151838 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180913 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 124489656 |a Opladen, Thomas |m 124489656:Opladen, Thomas |d 910000 |d 910500 |e 910000PO124489656 |e 910500PO124489656 |k 0/910000/ |k 1/910000/910500/ |p 4 | ||
| 999 | |a KXP-PPN1580952399 |e 3025502169 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1580952399","note":["Gesehen am 13.09.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency","title_sort":"Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1960","publisherPlace":"[Chicago, Ill.]","publisher":"Assoc.","dateIssuedDisp":"1960-2012"}],"name":{"displayForm":["American Medical Association"]},"language":["eng"],"disp":"Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiencyArchives of neurology","title":[{"title":"Archives of neurology","title_sort":"Archives of neurology"}],"pubHistory":["3.1960 - 69.2012"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"26876090X","part":{"text":"69(2012), 8, Seite 1071-1075","pages":"1071-1075","year":"2012","extent":"5","volume":"69","issue":"8"},"note":["Gesehen am 26.10.2016"],"id":{"issn":["1538-3687"],"eki":["26876090X"],"zdb":["1473074-1"]}}],"id":{"eki":["1580952399"],"doi":["10.1001/archneurol.2012.104"]},"name":{"displayForm":["Norbert Brüggemann, Juliane Spiegler, Yorck Hellenbroich, Thomas Opladen, Susanne A. Schneider, Ulrich Stephani, Rainer Boor, Gabriele Gillessen-Kaesbach, Jürgen Sperner, Christine Klein"]},"physDesc":[{"extent":"5 S."}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"April 2, 2012"}],"language":["eng"],"person":[{"family":"Brüggemann","role":"aut","roleDisplay":"VerfasserIn","given":"Norbert","display":"Brüggemann, Norbert"},{"family":"Opladen","display":"Opladen, Thomas","roleDisplay":"VerfasserIn","role":"aut","given":"Thomas"}]} | ||
| SRT | |a BRUEGGEMANBENEFICIAL2201 | ||